Cinnarizin Sofarma (Cinnarizinum) tablets 25 mg. №50

Description

Supportive treatment for symptoms of labyrinth disorders, including dizziness, nausea, vomiting, tinnitus, and nystagmus.
Prevention of motion sickness.
Migraine prevention.
Supportive treatment for symptoms of cerebrovascular origin, including dizziness, tinnitus, vascular headache, irritability, memory loss, and inability to concentrate.
Supportive treatment for symptoms of peripheral vascular disorders, including Raynaud’s disease, acrocyanosis, intermittent lameness, trophic disorders and varicose ulcers, paresthesia, night cramps in the limbs, and cold sensation in the limbs.